Skip to main content

Published locations for Lebrikizumab monotherapy for AD found safe, effective during induction

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Lebrikizumab monotherapy for AD found safe, effective during induction

User login

  • Reset your password
  • /content/lebrikizumab-monotherapy-ad-found-safe-effective-during-induction
  • /edermatologynews/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective
  • /familypracticenews/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective
  • /fedprac/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective-during
  • /internalmedicinenews/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe
  • /pediatricnews/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective
  • /pediatrics/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective-during
  • /internalmedicine/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective
  • /dermatology/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective-during
  • /familymedicine/article/261829/atopic-dermatitis/lebrikizumab-monotherapy-ad-found-safe-effective